Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NSFICorps_EL_T2
    Junior Member
    • Feb 2014
    • 2

    #1

    IonTorren PGM/Proton + Cloud vs. Illumina + Bioinformatics Core

    Hi Everyone,

    I posted a few weeks back introducing myself to the general forum (research scientist with the NSF I-Corps program). Since then, I've spent my time speaking to lab directors in clinical facilities (especially smaller labs). We've found that a lot of groups are opting for the IonTorrent PGM or Proton + Ingenuity pipeline for their next-gen work. Specifically, they've cited the fact that the cost is lower than Illumina and they don't need any bioinformaticians or computer cluster resources for post-run processing as influential factors. Thought I'd see if anyone here might weigh in. Both are very different approaches, and we're trying to understand if IonTorrent and cloud processing is really picking up steam with new/emerging clinical diagnostic labs. Any opinions/thoughts are welcomed. Thanks and have a good weekend!

    -Kevin
  • KevinLam
    Senior Member
    • Nov 2009
    • 204

    #2
    But they do sell you the compute server separately when you purchase the PGM yes?
    I have not heard about the Ingenuity pipeline but am interested to know more. for clinical diagnostics
    the fact that Ion PGM Dx is listed as a Class II medical device should make things interesting
    http://kevin-gattaca.blogspot.com/

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...